News Today Channel - The FDA has approved Baqsimi, a nasally administered glucagon, for treatment of severe hypoglycemia in people with diabetes four years & older. It is administered like a nasal
Baqsimi Glucagon Nasal Powder Spray 3mg — Mountainside Medical Equipment
Glucagon without Needles? Locemia's Intranasal Glucagon Powder for Severe Hypoglycemia
Advancing Diabetes Care: Longer Use FreeStyle Sensor, Nasal Glucagon
FDA Approves First Treatment for Severe Hypoglycemia That Can Be Administered without an Injection - Endocrine News
FDA approves first nasal glucagon powder for severe hypoglycemia
Glucagon Nasal Spray Effective for Hypoglycemia Rescue — JUICEBOX PODCAST
Nasal Glucagon Baqsimi Approved by the FDA - Beyond Type 2
First Look at Nasal Glucagon BAQSIMI
Baqsimi Will Make Your Glucagon Kit Obsolete
BAQSIMI Glucagon – First Nasal Glucagon Option - YouTube
Glucagon Options for People with Diabetes - Children with Diabetes
Eli Lilly, Aptar win FDA approval for nasal glucagon powder - MassDevice
Not to be sniffed at! Intranasal glucagon research noses towards spray replacing the red 'rescue' needle - JDRF, the type 1 diabetes charity